Another South Korean drug company has run afoul of the FDA after inspectors determined it had no quality checks in place and was handling manufacturing decisions with its contractor by phone. More: FDA bans products from Korean company that handled
read moreAs questions swirl over who knew what and when in the Philippines regarding Sanofi’s dengue vaccine, the company took a chance Wednesday to pause and explain its case. More: Sanofi looks for path forward with Dengvaxia as challenges mount Source:
read moreRoche’s Genentech is out with a new threat to Shire’s hemophilia franchise in the form of a bispecific antibody dubbed Hemlibra—but the Dublin drugmaker’s CEO, for one, says he isn’t too concerned. More: New Roche threat to Shire's hemophilia franchise?
read moreEli Lilly is betting that its new drugs will kick off an era of growth, but the company will have to contend with a tough environment in diabetes and a hefty patent expiration as it aims for 2018 revenue of $23 billion to
read moreSix months after Merck & Co.’s manufacturing operations were crippled by a global cyberattack, the company says it has mostly recovered from the computer hack that took out its API production and affected its formulation and packaging systems as well as
read moreSunovion Pharmaceuticals Europe, Bayer, Astellas UK, Astellas Europe and Menarini Pharma UK SRL have been named in adverts for breaching of the ABPI’s Code of Practice. More: Pharma companies fall foul of ABPI’s Code of Practice Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals